4
Changes in Ownership
Protagenic Therapeutics, Inc.\new Filed Acc 0001437749-16-031405
Options or other derivatives
- Chief Financial Officer bought 58,260 shares at $1.25 ($72,825)
From the SEC's structured data for this filing
Trades in this filing
Arrow Alexander K. · Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-04-15 | Purchase : show line 1 in the form Series B Preferred Stock | +40,000 | $1.25 | $50,000 | 100,000 | D |
| 2016-04-15 | Purchase : show line 2 in the form Series B Preferred Stock | +18,260 | $1.25 | $22,825 | 118,260 | I |
Loading xslF345X03/rdgdoc.xml…